AM AM - Resmed Founder Chairman
| RSMDFDelisted Stock | USD 17.70 0.00 0.00% |
Insider
AM AM is Founder Chairman of Resmed Inc DRC
| Age | 80 |
| Phone | 858 836 5000 |
| Web | https://www.resmed.com |
Resmed Management Efficiency
The company has return on total asset (ROA) of 0.1155 % which means that it generated a profit of $0.1155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2352 %, meaning that it generated $0.2352 on every $100 dollars invested by stockholders. Resmed's management efficiency ratios could be used to measure how well Resmed manages its routine affairs as well as how well it operates its assets and liabilities.Resmed Inc DRC has accumulated 765.33 M in total debt with debt to equity ratio (D/E) of 0.27, which may suggest the company is not taking enough advantage from borrowing. Resmed Inc DRC has a current ratio of 2.74, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Resmed until it has trouble settling it off, either with new capital or with free cash flow. So, Resmed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Resmed Inc DRC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Resmed to invest in growth at high rates of return. When we think about Resmed's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Brian Bonnell | ICU Medical | 50 | |
| Amy McbrideWendell | Baxter International | 60 | |
| B Owens | AptarGroup | 66 | |
| James Borzi | Baxter International | 61 | |
| Joseph Pierce | Merit Medical Systems | N/A | |
| Matthew DellaMaria | AptarGroup | N/A | |
| Cindy ReissClark | West Pharmaceutical Services | 50 | |
| Heidi Tlili | AptarGroup | 49 | |
| Kimberly Chainey | AptarGroup | 48 | |
| Candace Matthews | AptarGroup | 61 | |
| Nicole Priest | Merit Medical Systems | N/A | |
| Isabel MareySemper | AptarGroup | 53 | |
| Jenwei Wu | AptarGroup | 64 | |
| A Bender | The Cooper Companies, | 79 | |
| Michel Voigt | Merit Medical Systems | 51 | |
| Jason Treft | Merit Medical Systems | N/A | |
| Richard Luzzi | West Pharmaceutical Services | 72 | |
| Brian Capone | Embecta Corp | 49 | |
| Robert Segura | West Pharmaceutical Services | N/A | |
| Vered Keisar | ResMed Inc | N/A | |
| BE MBA | ResMed Inc | 50 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 |
Resmed Inc DRC Leadership Team
Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham, VP Communications | ||
| Brett Sandercock, CFO and Principal Accounting Officer | ||
| BE MBA, CEO Director | ||
| Robert Douglas, Pres and COO | ||
| Vered Keisar, Chief Officer | ||
| David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary | ||
| AM AM, Founder Chairman | ||
| Kaushik Ghoshal, Pres Bus | ||
| Constance Bienfait, Director Relations | ||
| Urvashi Tyagi, Chief Officer |
Resmed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Resmed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 33.08 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.93 % | |||
| Price To Earning | 28.58 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 9.04 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |